UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

First in human study with GSK3359609 [GSK609], inducible T cell co-stimulator (ICOS) receptor agonist in patients [Pts] with advanced, solid tumors: Preliminary results from INDUCE-1

Annals of oncology, 2018-10, Vol.29, p.viii404-viii404

2018

Volltextzugriff (PDF)

Preclinical evaluation of a non-depleting, first-in-class humanized IgG4 agonist anti-ICOS antibody

Annals of oncology, 2018-10, Vol.29, p.viii652-viii653

2018

Volltextzugriff (PDF)

Medulloblastoma rendered susceptible to NK-cell attack by TGFß neutralization

Cytotherapy (Oxford, England), 2019-05, Vol.21 (5), p.S26-S27

2019

Volltextzugriff (PDF)

Superficial Cervical Plexus Block in Selective Cases of Oral and Maxillofacial Surgery as an Alternative to General Anesthesia: A Case Presentation

Curēus (Palo Alto, CA), 2022-01

2022

Volltextzugriff (PDF)

Clinical relevance of cyclooxygenase 2 and peroxisome proliferator-activated receptor γ in eyelid sebaceous gland carcinoma

Histopathology, 2016-08, Vol.69 (2), p.268-275

2016

Volltextzugriff (PDF)

Clinical relevance of cyclooxygenase 2 and peroxisome proliferator-activated receptor [gamma] in eyelid sebaceous gland carcinoma

Histopathology, 2016-08, Vol.69 (2), p.268

2016

Volltextzugriff (PDF)

Ribosomal protein S3: A multi-functional protein that interacts with both p53 and MDM2 through its KH domain

DNA repair, 2009-10, Vol.8 (10), p.1215-1224

2009

Volltextzugriff (PDF)

Manganese-containing Prussian blue nanoparticles for imaging of pediatric brain tumors

International journal of nanomedicine, 2014-01, Vol.9 (Issue 1), p.2581-2595

2014

Volltextzugriff (PDF)

11P Pharmacokinetic/pharmacodynamic (PK/PD) exposure-response characterization of GSK3359609 (GSK609) from INDUCE-1, a phase I open-label study

Annals of oncology, 2020-03, Vol.31, p.S3

2020

Volltextzugriff (PDF)

1971P - Pharmacokinetic/ pharmacodynamic (PK/PD) exposure-response characterization of GSK3359609 (GSK609) from INDUCE-1, a phase I open-label study

Annals of oncology, 2019-10, Vol.30, p.v793-v793

2019

Volltextzugriff (PDF)

Pharmacokinetic/ pharmacodynamic (PK/PD) exposure-response characterization of GSK3359609 (GSK609) from INDUCE-1, a phase I open-label study

Annals of oncology, 2019-10, Vol.30, p.v793

2019

Volltextzugriff (PDF)

P1.01-110 Novel Regimens Versus Standard-of-Care in NSCLC: A Phase II, Randomized, Open-Label, Platform Trial Using a Master Protocol

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S404-S405

2019

Volltextzugriff (PDF)

1971PPharmacokinetic/ pharmacodynamic (PK/PD) exposure-response characterization of GSK3359609 (GSK609) from INDUCE-1, a phase I open-label study

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

Immunodynamics of explanted human tumors for immuno‐oncology

EMBO molecular medicine, 2021-01, Vol.13 (1), p.e12850-n/a

2021

Volltextzugriff (PDF)

1138PDFirst in human study with GSK3359609 [GSK609], inducible T cell co-stimulator (ICOS) receptor agonist in patients [Pts] with advanced, solid tumors: Preliminary results from INDUCE-1

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

1840PPreclinical evaluation of a non-depleting, first-in-class humanized IgG4 agonist anti-ICOS antibody

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

SC-37 THE ROLE OF NG2 EXPRESSING PROGENITOR CELLS IN DIFFUSE INTRINSIC PONTINE GLIOMA

Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (suppl 5), p.v205-v205

2014

Volltextzugriff (PDF)

ET-64 PRE-CLINICAL ASSESSMENT OF DISSOCIATIVE STEROIDS AS DEXAMETHASONE SUBSTITUTE FOR TREATMENT IN DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)

Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (suppl 5), p.v93-v93

2014

Volltextzugriff (PDF)

Translocation of human ribosomal protein S3 to sites of DNA damage is dependant on ERK-mediated phosphorylation following genotoxic stress

DNA repair, 2007-10, Vol.6 (10), p.1453-1462

2007

Volltextzugriff (PDF)

NI-44 LIPOSOMAL NANOPARTICLES FOR TARGETING AND IMAGING OF PEDIATRIC BRAIN TUMORS

Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (suppl 5), p.v147-v148

2014

Volltextzugriff (PDF)

PM-20 COMPARATIVE PROTEOME PROFILING OF IN VIVO AND IN VITRO MODELS OF DIPG

Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (suppl 5), p.v173-v173

2014

Volltextzugriff (PDF)

BT-04 A STANDARDIZED AUTOPSY PROCUREMENT ALLOWS FOR THE COMPREHENSIVE STUDY OF DIPG BIOLOGY

Neuro-oncology (Charlottesville, Va.), 2015-06, Vol.17 (suppl 3), p.iii4-iii4

2015

Volltextzugriff (PDF)

Knockdown of ribosomal protein S3 protects human cells from genotoxic stress

DNA repair, 2007-01, Vol.6 (1), p.94-99

2007

Volltextzugriff (PDF)

Combination of paxalisib and ONC201 for the treatment of diffuse intrinsic pontine glioma

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, Vol.17, p.56

2021

Volltextzugriff (PDF)

Diepoxybutane activates the mitochondrial apoptotic pathway and mediates apoptosis in human lymphoblasts through oxidative stress

Toxicology in vitro, 2007-12, Vol.21 (8), p.1429-1441

2007

Volltextzugriff (PDF)

1 – 25 von 163

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(148)
Mit Volltextzugriff
(151)

Publikationsform

Sprache

Englisch
(163)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

First in human study with GSK3359609 [GSK609], inducible T cell co-stimulator (ICOS) receptor agonist in patients [Pts] with advanced, solid tumors: Preliminary results from INDUCE-1

Preclinical evaluation of a non-depleting, first-in-class humanized IgG4 agonist anti-ICOS antibody

Medulloblastoma rendered susceptible to NK-cell attack by TGFß neutralization

Superficial Cervical Plexus Block in Selective Cases of Oral and Maxillofacial Surgery as an Alternative to General Anesthesia: A Case Presentation

Clinical relevance of cyclooxygenase 2 and peroxisome proliferator-activated receptor γ in eyelid sebaceous gland carcinoma

Clinical relevance of cyclooxygenase 2 and peroxisome proliferator-activated receptor [gamma] in eyelid sebaceous gland carcinoma

Ribosomal protein S3: A multi-functional protein that interacts with both p53 and MDM2 through its KH domain

Manganese-containing Prussian blue nanoparticles for imaging of pediatric brain tumors

11P Pharmacokinetic/pharmacodynamic (PK/PD) exposure-response characterization of GSK3359609 (GSK609) from INDUCE-1, a phase I open-label study

1971P - Pharmacokinetic/ pharmacodynamic (PK/PD) exposure-response characterization of GSK3359609 (GSK609) from INDUCE-1, a phase I open-label study

Pharmacokinetic/ pharmacodynamic (PK/PD) exposure-response characterization of GSK3359609 (GSK609) from INDUCE-1, a phase I open-label study

P1.01-110 Novel Regimens Versus Standard-of-Care in NSCLC: A Phase II, Randomized, Open-Label, Platform Trial Using a Master Protocol

1971PPharmacokinetic/ pharmacodynamic (PK/PD) exposure-response characterization of GSK3359609 (GSK609) from INDUCE-1, a phase I open-label study

Immunodynamics of explanted human tumors for immuno‐oncology

1138PDFirst in human study with GSK3359609 [GSK609], inducible T cell co-stimulator (ICOS) receptor agonist in patients [Pts] with advanced, solid tumors: Preliminary results from INDUCE-1

1840PPreclinical evaluation of a non-depleting, first-in-class humanized IgG4 agonist anti-ICOS antibody

SC-37 THE ROLE OF NG2 EXPRESSING PROGENITOR CELLS IN DIFFUSE INTRINSIC PONTINE GLIOMA

ET-64 PRE-CLINICAL ASSESSMENT OF DISSOCIATIVE STEROIDS AS DEXAMETHASONE SUBSTITUTE FOR TREATMENT IN DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)

Translocation of human ribosomal protein S3 to sites of DNA damage is dependant on ERK-mediated phosphorylation following genotoxic stress

NI-44 LIPOSOMAL NANOPARTICLES FOR TARGETING AND IMAGING OF PEDIATRIC BRAIN TUMORS

PM-20 COMPARATIVE PROTEOME PROFILING OF IN VIVO AND IN VITRO MODELS OF DIPG

BT-04 A STANDARDIZED AUTOPSY PROCUREMENT ALLOWS FOR THE COMPREHENSIVE STUDY OF DIPG BIOLOGY

Knockdown of ribosomal protein S3 protects human cells from genotoxic stress

Combination of paxalisib and ONC201 for the treatment of diffuse intrinsic pontine glioma

Diepoxybutane activates the mitochondrial apoptotic pathway and mediates apoptosis in human lymphoblasts through oxidative stress

Suchergebnisse filtern